How Far Are we Away From an Improved Vaccine For Tuberculosis? Current Efforts and Future Prospects.


Journal

Archivos de bronconeumologia
ISSN: 2173-5751
Titre abrégé: Arch Bronconeumol (Engl Ed)
Pays: Spain
ID NLM: 101777538

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 27 07 2018
revised: 12 11 2018
accepted: 12 11 2018
pubmed: 31 12 2018
medline: 6 10 2020
entrez: 31 12 2018
Statut: ppublish

Résumé

Tuberculosis still is a major public health problem worldwide, and vaccines may play a major role in its eradication. However, despite 20 years of intensive research, we still do not have a better vaccine than the Bacille Calmette-Guérin vaccine, which has been used since 1921 but exhibits only limited efficacy in the field. This effort has not, however, been entirely in vain as our understanding of TB vaccinology has been substantially expanded and there are currently 17 vaccine candidates in clinical development and several more in preclinical trials. This manuscript reviews the most important recent advances, concerns raised and future prospects in the TB vaccinology field.

Identifiants

pubmed: 30594319
pii: S0300-2896(18)30446-0
doi: 10.1016/j.arbres.2018.11.002
pii:
doi:

Substances chimiques

Adjuvants, Immunologic 0
Antibodies, Bacterial 0
Antigens, Bacterial 0
BCG Vaccine 0
Tuberculosis Vaccines 0
Vaccines, Subunit 0
Vaccines, Synthetic 0

Types de publication

Journal Article Review

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

373-377

Informations de copyright

Copyright © 2018 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Cristina Vilaplana (C)

Experimental Tuberculosis Unit (UTE), Fundació Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona (UAB), Can Ruti Campus, Badalona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain. Electronic address: cvilaplana@gmail.com.

Pere-Joan Cardona (PJ)

Experimental Tuberculosis Unit (UTE), Fundació Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona (UAB), Can Ruti Campus, Badalona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH